Allurion Technologies (ALUR) Depreciation & Amortization (CF) (2022 - 2026)
Allurion Technologies (ALUR) posted Depreciation & Amortization (CF) of $171000.0 for Q1 2026, up 3.64% on a QoQ basis from $165000.0 in Q4 2025, and down 15.76% year-over-year from $203000.0 in Q1 2025.
Allurion Technologies (ALUR) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends
Allurion Technologies' Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $171000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 15.76% year-over-year to $171000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $949000.0 (up 13.79% YoY) and the FY2025 annual result came in at $983000.0, down 1.4% from the prior year.
- Depreciation & Amortization (CF) was $171000.0 for Q1 2026 at Allurion Technologies, up from $165000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $367000.0 in Q1 2024 and bottomed at $154000.0 in Q2 2023.
- A 5-year average of $223687.5 and a median of $212500.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Peak annual rise in Depreciation & Amortization (CF) reached 75.63% in 2025, while the deepest fall reached 44.69% in 2025.
- Allurion Technologies' Depreciation & Amortization (CF) stood at $243000.0 in 2022, then dropped by 22.63% to $188000.0 in 2023, then grew by 16.49% to $219000.0 in 2024, then decreased by 24.66% to $165000.0 in 2025, then gained by 3.64% to $171000.0 in 2026.
- Business Quant data shows ALUR's Depreciation & Amortization (CF) at $171000.0 in Q1 2026, $165000.0 in Q4 2025, and $267000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | 171,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 171,000.00 |
| Mar 31, 2026 | 171,000.00 |
| Dec 31, 2025 | 165,000.00 |
| Dec 31, 2025 | 165,000.00 |
| Sep 30, 2025 | 267,000.00 |
| Sep 30, 2025 | 267,000.00 |
| Jun 30, 2025 | 346,000.00 |
| Jun 30, 2025 | 346,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Sep 30, 2024 | 215,000.00 |
| Sep 30, 2024 | 215,000.00 |
| Jun 30, 2024 | 197,000.00 |
| Jun 30, 2024 | 197,000.00 |
| Mar 31, 2024 | 367,000.00 |
| Mar 31, 2024 | 367,000.00 |
| Dec 31, 2023 | 188,000.00 |
| Dec 31, 2023 | 188,000.00 |